You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenoviral conjunctivitis

Showing 1 - 25 of 336
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Adenoviral Conjunctivitis Trial in Andover, Noida (FST-100, FST-100 (Component #1), FST-100 Vehicle)

Completed
  • Acute Adenoviral Conjunctivitis
  • Andover, Massachusetts
  • +1 more
Jun 23, 2021

Acute Adenoviral Conjunctivitis Trial in United States (FST-100 Ophthalmic Suspension, Placebo)

Terminated
  • Acute Adenoviral Conjunctivitis
  • FST-100 Ophthalmic Suspension
  • Placebo
  • Torrance, California
  • +12 more
Aug 22, 2021

Conjunctivitis Trial in United States (RPS Adeno Detector IV)

Completed
Has Results
  • Conjunctivitis
  • RPS Adeno Detector IV
  • Bradenton, Florida
  • +7 more
Nov 1, 2021

Conjunctivitis, Adenoviral Conjunctivitis Trial in Saint Louis (Betadine 5%, Artificial Tears)

Completed
Has Results
  • Conjunctivitis
  • Adenoviral Conjunctivitis
  • Betadine 5%
  • Artificial Tears
  • Saint Louis, Missouri
    Mary Migneco
Jan 4, 2021

Adenoviral Conjunctivitis Trial in Kolkata (IVIEW-1201, Placebo)

Unknown status
  • Adenoviral Conjunctivitis
  • Kolkata, West Bengal, India
    Disha Eye Hospital
Dec 29, 2019

Viral Conjunctivitis Trial in Miami (0.01% Hypochlorous acid, Placebo)

Terminated
Has Results
  • Viral Conjunctivitis
  • 0.01% Hypochlorous acid
  • Placebo
  • Miami, Florida
    University of Miami Bascom Palmer Eye Institute
Nov 29, 2021

Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)

Not yet recruiting
  • Ebola Sudan Virus Disease
  • cAD3-Sudan Ebolavirus Vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Sep 7, 2023

Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Nov 29, 2023

Marburg Virus Disease Trial in Siaya, Kampala (cAd3-Marburg vaccine, Placebo)

Not yet recruiting
  • Marburg Virus Disease
  • cAd3-Marburg vaccine
  • Placebo
  • Siaya, Kenya
  • +1 more
Apr 17, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Conjunctivitis in Setting of DUPIXENT® Treatment for Atopic

Active, not recruiting
  • Conjunctivitis
  • Atopic Dermatitis
  • Irvine, California
  • +14 more
Jul 8, 2022

Ligneous Conjunctivitis Trial in Indianapolis, Florence, Padova (Human Plasminogen)

Completed
Has Results
  • Ligneous Conjunctivitis
  • Human Plasminogen
  • Indianapolis, Indiana
  • +2 more
Jan 2, 2023

Ebola Virus Disease, Marburg Virus Disease Trial in Oklahoma City (cAd3-Marburg, cAd3-EBO-S)

Completed
  • Ebola Virus Disease
  • Marburg Virus Disease
  • cAd3-Marburg
  • cAd3-EBO-S
  • Oklahoma City, Oklahoma
    Oklahoma Blood Institute (OBI)
Aug 2, 2022

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic

Not yet recruiting
  • Seasonal Allergic Conjunctivitis
  • Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
  • +3 more
  • Andover, Massachusetts
  • +1 more
Nov 9, 2022

Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)

Not yet recruiting
  • Acute Bacterial Conjunctivitis
  • (no location specified)
Apr 13, 2023

COVID-19 Trial in Adelaide (SpikoGen vaccine)

Not yet recruiting
  • COVID-19
  • SpikoGen vaccine
  • Adelaide, South Australia, Australia
    ARASMI
Sep 13, 2022

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Dry Eye Trial in Japan (OPC-12759, Placebo)

Completed
Has Results
  • Dry Eye
  • Kansai Region, Japan
  • +3 more
Apr 12, 2021

Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)

Completed
Has Results
  • Allergic Conjunctivitis
  • PRT-2761 0.5%
  • +4 more
  • Andover, Massachusetts
    Andover Eye Associates
Oct 13, 2022

Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)

Completed
  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Eye Drops, Solution in Single-Dose Container
  • Vienna, Austria
    Vienna Challenge Chamber
Aug 24, 2022

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

Acute Infectious Conjunctivitis (Disorder) Trial in Jackson Heights (SCH-1, Placebo)

Recruiting
  • Acute Infectious Conjunctivitis (Disorder)
  • Jackson Heights, New York
    Jacqueline Dauhajre, MD
Apr 26, 2022